MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

L. Esserman, E. Kaplan, S. Partridge, D. Tripathy, H. Rugo, J. Park, S. Hwang, H. Kuerer, D. Sudilovsky, Y. Lu, N. Hylton

Research output: Contribution to journalArticlepeer-review

131 Scopus citations

Fingerprint

Dive into the research topics of 'MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences